GM-2505

· Gilgamesh Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GM-2505, covering 2026-02-09 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2a Study to Evaluate the Safety and Tolerability of GM-2505 in Patients With MDD [Phase 2]